仟源医药(300254.SZ)：董事及高管团队拟减持公司股份

Core Viewpoint - QianYuan Pharmaceutical (300254.SZ) announced that several executives plan to reduce their holdings in the company within three months after a 15 trading day period from the announcement date [1] Summary by Relevant Categories Shareholding Reduction - Executive Yu Junxian plans to reduce holdings by up to 289,200 shares, accounting for 0.1165% of the total share capital of the company [1] - Executive Gu Baoping plans to reduce holdings by up to 43,700 shares, accounting for 0.0176% of the total share capital of the company [1] - Executive Yu Yingmin plans to reduce holdings by up to 43,700 shares, accounting for 0.0176% of the total share capital of the company [1] - Executive He Yanjie plans to reduce holdings by up to 25,000 shares, accounting for 0.0101% of the total share capital of the company [1] - Executive Luo Kairui plans to reduce holdings by up to 25,000 shares, accounting for 0.0101% of the total share capital of the company [1]